References
-
1
Fahmy M, Skacel M, Gramlich T. et al .
Chromosomal gains and genomic loss of p53 and p16 genes in Barrett’s esophagus detected by flourescence in situ hybridization of cytology specimens.
Modern Pathology.
2004;
17
588-596
-
2
Zagorowicz E, Jankowski J.
Molecular changes in the progression of Barrett’s oesophagus. Systematic review of molecular biomarkers, regarding the ASPECT study in the UK.
Post Grad Med J.
2007;
83
529-535
-
3
Tischoff I, Tannapfel A.
Barrett’s esophagus: can biomarkers predict progression to malignancy?.
Expert Rev Gastroenterol Hepatol.
2008;
2
653-663
-
4
Saad S R, Mahood K L, Clary M K. et al .
Role of cytology in the diagnosis of Barretts esophagus and associated neoplasia.
Diagn Cytopathol.
2003;
29
130-135
-
5
Huang Q, Hardie L J.
Biomarkers in Barrett’s oesophagus.
Biochemical Society Transaction.
2010;
38
343-347
-
6
Spechler S J.
Clinical practice. Barrett’s Esophagus.
N Engl J Med.
2002;
346
836-842
-
7
Kumaravel A, Lopez R, Brainard J, Falk G W.
Brush cytology vs. endoscopic biopsy for the surveillance of Barrett’s esophagus.
Endoscopy.
2010;
10
800-805
-
8
Geisinger K R, Teot L A, Richter J E.
A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett’s esophagus.
Cancer.
1992;
69
8-16
-
9
Robey S S, Hamilton S R, Gupta P K, Erozan Y S.
Diagnostic value of cytopathology in Barrett esophagus and associated carcinoma.
Am J Clin Pathol.
1988;
89
493-498
-
10
Hardwick R H, Morgan R J, Warren B F. et al .
Brush cytology in the diagnosis of neoplasia in Barrett’s esophagus.
Dis Esophagus.
1997;
10
233-237
-
11
Fritcher E G, Brankley S M, Kipp B R. et al .
A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett’s esophagus.
Hum Pathol.
2008;
39
1128-1135
-
12
Falk G W.
Cytology in Barrett’s esophagus.
Gastrointest Endosc Clin N Am.
2003;
13
335-348
-
13
Falk G W, Chittajallu R, Goldblum J R. et al .
Surveillance of patients with Barrett’s esophagus for dysplasia and cancer with balloon cytology.
Gastroenterology.
1997;
112
1787-1797
-
14
Brankley S, Wang K K, Harwood A R. et al .
The development of a flourescence in situ hybridisation assay for the detection of dysplasia and adenocarcinoma in Barrett’s esophagus.
J Mol Diagn.
2006;
8
260-267
-
15
Rygiel A, van Baal W, Milano F. et al .
Efficient automated assessment of genetic abnormalities detected by flourescent in situ hybridization on brush cytology of a Barrett’s esophagus surveillance population.
Cancer.
2007;
109
1980-1988
-
16
Rygiel A, van Baal W, Milano F. et al .
Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett’s esophagus brush cytology specimens.
Genes Chromosomes Cancer.
2008;
47
396-404
-
17
Kerkhof M, Kusters J, van Dekken H. et al .
Biomarkers for risk stratification of neoplastic progression in Barrett esophagus.
Cell Oncol.
2007;
29
507-517
K. K. KrishnadathMD
Department of Gastroenterology and Hepatology
Academic Medical Center
Meibergdreef 9
Amsterdam 1100 DD
The Netherlands
Fax: +31-20-6917033
Email: k.k.krishnadath@amc.uva.nl
